Offer - Urjas Oil for just ₹ 1 X
Wergomet 0.125 Mg Tablet is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Post Delivery Bleeding.
The correct dosage of Wergomet 0.125 Mg Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Wergomet 0.125 Mg Tablet are Headache, Abdominal Pain, Hypertension. While these are the most often observed Wergomet 0.125 Mg Tablet side effects, there are can be others also. These have been listed below. Such side effects of Wergomet 0.125 Mg Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Wergomet 0.125 Mg Tablet has a Unknown effect for pregnant women and Unknown effect on lactating mothers. In addition, Wergomet 0.125 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Wergomet 0.125 Mg Tablet related warnings section.
Individuals suffering from medical conditions like High Blood Pressure must refrain from the use of Wergomet 0.125 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Wergomet 0.125 Mg Tablet are listed in the contraindications section below.
Besides this, Wergomet 0.125 Mg Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Wergomet 0.125 Mg Tablet is considered safe while driving, and is addictive.
Wergomet 0.125 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Wergomet 0.125 Mg Tablet safe for pregnant women?
The effects of Wergomet on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Wergomet 0.125 Mg Tablet safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Wergomet for breastfeeding women are not known.
What is the effect of Wergomet 0.125 Mg Tablet on the Kidneys?
Wergomet rarely harms the kidneys.
What is the effect of Wergomet 0.125 Mg Tablet on the Liver?
Wergomet can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Wergomet 0.125 Mg Tablet on the Heart?
Wergomet may have severe effects on your heart, so do not take it without first consulting your doctor.
If you are suffering from any of the following diseases, you should not take Wergomet 0.125 Mg Tablet unless your doctor advises you to do so -
Is this Wergomet 0.125 Mg Tablet habit forming or addictive?
Wergomet 0.125 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Wergomet 0.125 Mg Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Wergomet 0.125 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Wergomet 0.125 Mg Tablet is unable to treat or cure mental disorders.
Interaction between Food and Wergomet 0.125 Mg Tablet
There is no information on the effects of taking Wergomet 0.125 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Wergomet 0.125 Mg Tablet
Due to lack of research, there is no information about the side effects of taking Wergomet 0.125 Mg Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839